Search results
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks· 1 day agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biopharmaceutical company have returned -4.8%, compared to the Zacks S&P 500 ...
Birchview Capital LP Has $36.04 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 1 day agoBirchview Capital LP cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.0% during the fourth quarter, according to the company ...
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Digital Journal· 2 days agoBristol Myers Squibb and our shared commitment to innovation and patient care. Together with Bristol Myers Squibb ...
Smart Money Is Betting Big In BMY Options - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 7 days agoPresent Market Standing of Bristol-Myers Squibb With a volume of 13,207,471, the price of BMY is up 1.35% at $41.43. RSI indicators hint that the underlying ...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 4 days agoImmune drug developers account for only two of the 11 new biotech stock issuances this year. But...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 7 days agoVGM Scores Currently, Prothena has a poor Growth Score of F, however its Momentum Score is doing a...
7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)
InvestorPlace· 4 days agoThe Oracle of Omaha is by far the most well-known long-term investor we have alive today, and if you...
The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024
InvestorPlace· 6 days agoFor many investors, especially those who are just building a portfolio, undervalued stocks under $50...